MBrace Therapeutics
San Diego
About MBrace Therapeutics
MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $110.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2023)
- Website: mbracetrx.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/mbrace-therapeutics-52504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.